HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.

Sci Rep · 2022 · PMC9334272 · PMID 35902644

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In line with the ER+ cohort, gene-expression analyses of the ER- cohort also showed a trend toward higher expression of ERAL1 , MED24 and PGAP3 for the HER2low cases, although this was not significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.